International Publications Archive - IOZK

Long-term follow up of patients with mesothelioma treated with dendritic cell therapy in three phase I trials.

2021-08-09/in Dendritic Cells, International Publications, Malignant Melanoma /von 2021-08-09 / J Clin Oncol 39, 2021 (suppl 15; abstr 2618)

Phase 1 trial of autologous dendritic cell vaccination with imiquimod immunomodulation in children and adults with refractory sarcoma.

2021-08-09/in Dendritic Cells, International Publications, Soft Tissue Sarcoma /von 2021-08-09 / J Clin Oncol 39, 2021 (suppl 15; abstr 11542)

Safety and efficacy of autologous tumor lysate particle-loaded dendritic cell vaccination in combination with systemic therapies in patients with recurrent and metastatic melanoma

2021-08-01/in Dendritic Cells, International Publications, Malignant Melanoma /von 2021-08-01 / Melanoma Res 2021 08;31(4):378-388

Evaluation of the oncolytic property of recombinant Newcastle disease virus strain R2B in 4T1 and B16-F10 cells in-vitro

2021-07-25/in International Publications, Newcastle Disease Virus /von 2021-07-25 / Res Vet Sci 2021 Jul;139:159-165

Ex vivo dendritic cell-based (DC) vaccine pulsed with a low dose of liposomal antigen and CpG-ODN improved PD-1 blockade immunotherapy

2021-07-19/in Checkpoint-Inhibitors, Dendritic Cells, International Publications, Malignant Melanoma /von 2021-07-19 / Sci Rep 2021 Jul;11(1):14661

Stem cells-derived natural killer cells for cancer immunotherapy: current protocols, feasibility, and benefits of ex vivo generated natural killer cells in treatment of advanced solid tumors

2021-07-04/in International Publications /von 2021-07-04 / Cancer Immunol Immunother 2021 Jul;

Insights Into Dendritic Cells in Cancer Immunotherapy: From Bench to Clinical Applications

2021-06-28/in Dendritic Cells, International Publications /von 2021-06-28 / Front Cell Dev Biol 2021;9:686544

Recombinant Newcastle disease virus immunotherapy drives oncolytic effects and durable systemic antitumor immunity

2021-06-17/in International Publications, Newcastle Disease Virus /von 2021-06-17 / Mol Cancer Ther 2021 Jun;

Immunotherapeutic Approaches in Malignant Pleural Mesothelioma

2021-06-04/in Dendritic Cells, International Publications, Malignant Pleural Mesothelioma /von 2021-06-04 / Cancers (Basel) 2021 Jun;13(11)

A phase I study to evaluate the safety and effectiveness of neoantigen-based personalized dendritic cell vaccine in patients with advanced solid tumors.

2021-06-04/in Dendritic Cells, International Publications /von 2021-06-04 / J Clin Oncol 39, 2021 (suppl 15; abstr e14512)